| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $269.7M | -29.8% |
| Cost of Revenue | $30.7M | +24.3% |
| R&D Expense | $52.3M | +13.6% |
| SG&A Expense | $163.0M | +20.7% |
| Operating Income | -$421.4M | -46.8% |
| Interest Expense | $24.0M | +1863.3% |
| Pre-tax Income | -$439.2M | -119.2% |
| Income Tax | -$345K | +98.2% |
| Net Income | -$438.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $362.5M | +50.2% |
| Accounts Receivable | $7.2M | -46.8% |
| Current Assets | $501.7M | -15.1% |
| Total Assets | $621.3M | -39.3% |
| Current Liabilities | $49.5M | -43.0% |
| Long-term Debt | $272.8M | -2.2% |
| Total Liabilities | $342.9M | -14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$179.6M | +0.3% |
| Investing Cash Flow | $311.4M | +148.4% |
| Financing Cash Flow | -$10.6M | -101.3% |
| -142.0% |
| EPS (Basic) | -$1.07 | -127.7% |
| EPS (Diluted) | -$1.07 | -55.1% |
| Stockholders' Equity |
| $278.4M |
| -55.4% |